bioRxivImmunology
Persistent Immune and Clotting Dysfunction Detected in Saliva and Blood Plasma after COVID-19
H. Jang, S. Choudhury, Y. Yu, B. L. Sievers, T. Gelbart, H. Singh, S. A. Rawlings, A. Proal, G. S. Tan, D. Smith, M. Freire
Abstract
A growing number of studies indicate that coronavirus disease 2019 (COVID-19) is associated with inflammatory sequelae, but molecular signatures governing the normal vs. pathologic convalescence process have not been well-delineated. We characterized global immune and proteome responses in matched plasma and saliva samples obtained from COVID-19 patients collected between 4-6 weeks after initial clinical symptoms resolved. Convalescent subjects showed robust IgA and IgG responses and positive antibody correlations between matched saliva and plasma samples. However, global shotgun proteomics revealed persistent inflammatory patterns in convalescent samples including dysfunction of salivary innate immune cells and clotting factors in plasma (e.g., fibrinogen and antithrombin), with positive correlations to acute COVID-19 disease severity. Saliva samples were characterized by higher concentrations of IgA, and proteomics showed altered pathways that correlated positively with IgA levels. Our study positions saliva as a viable fluid to monitor immunity beyond plasma to document COVID-19 immune, inflammatory, and coagulation-related sequelae.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Complex changes in serum protein levels in COVID-19 convalescents
S. Pushalkar, S. Wu, … C. Vogel·bioRxiv·Oct 26, 2022
- Reduced Monocyte Proportions and Responsiveness in Convalescent COVID-19 Patients
E. Ravkov, E. S. C. P. Williams, … T. Hanley·bioRxiv·Oct 25, 2023
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Feargal J. Ryan, Christopher M. Hope, … David John Lynn·BMC MedicinePeer-reviewed·Jan 13, 2022
- Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals
Guillaume Beaudoin-Bussières, Annemarie Laumaea, … Andrés Finzi·bioRxiv·Jul 9, 2020
- Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
N. Sherina, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Nov 6, 2020